# ClinicalTrials.gov record NCT03072147

> PeptideScanner retained ClinicalTrials.gov record NCT03072147 at 2026-07-30T19:13:03.748Z. Its registry update date was 2023-05-12, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct03072147-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-05-12
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03072147-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03072147-teriparatide-v1.json
- Content SHA-256: `efeaae99a8606fe78cdc4fe40dda46bae04adcca9f22dfd9e06115147a606cf0`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT03072147 ([`ctg-observation-nct03072147-2023-05-12-c5f4934ff99a`](#source-ctg-observation-nct03072147-2023-05-12-c5f4934ff99a))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03072147 at 2026-07-30T19:13:03.748Z. Its registry update date was 2023-05-12, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct03072147-2023-05-12-c5f4934ff99a`](#source-ctg-observation-nct03072147-2023-05-12-c5f4934ff99a))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03072147 at 2026-07-30T19:13:03.748Z. Its registry update date was 2023-05-12, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct03072147-2023-05-12-c5f4934ff99a`](#source-ctg-observation-nct03072147-2023-05-12-c5f4934ff99a))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03072147-2023-05-12-c5f4934ff99a`](#source-ctg-observation-nct03072147-2023-05-12-c5f4934ff99a))

## Sources

<a id="source-ctg-observation-nct03072147-2023-05-12-c5f4934ff99a"></a>
- **ClinicalTrials.gov record NCT03072147 · retained source version 2023-05-12:c5f4934ff99aa44ba8e86eb4064f91c9195f57e68d1aa914a1d9d97905fab3b0** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03072147) (`ctg-observation-nct03072147-2023-05-12-c5f4934ff99a`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03072147." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct03072147-teriparatide-v1.json SHA-256: efeaae99a8606fe78cdc4fe40dda46bae04adcca9f22dfd9e06115147a606cf0.